603567.SHG Heilongjiang ZBD Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
5.03 CNY
Close of Nov 4, 2026
4.21 11.90
Market cap
CNY 4.73B
P/E
-
P/B
0.79x
ROE
-11.1%
Dividend yield
5.85%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603567.SHG undervalued?

Graham number

The Graham number of Heilongjiang ZBD Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Heilongjiang ZBD Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Heilongjiang ZBD Pharmaceutical Co Ltd yet.

Heilongjiang ZBD Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Heilongjiang ZBD Pharmaceutical Co Ltd

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufacturing of pharmaceuticals; pharmaceutical retail and wholesale; testing and inspect…

Full company profile